SPILSBY SURGERY — All Prescriptions & Medications — Page 11
Practice Code: C83005 | SPILSBY, PE23 5LG
Showing results 501-550 of 593
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nicotine | 16 | 236 | £369 | -71.7% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 16 | 558 | £27 | -60.2% ▼ |
| RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | 16 | 96.4K | £1.0K | +34.2% ▲ |
| Methocarbamol | 16 | 1,326 | £88 | -66.6% ▼ |
| Clindamycin/tretinoin | 16 | 480 | £182 | +36.3% ▲ |
| 16 | 100 | £291 | -51.2% ▼ | |
| 16 | 16 | £3.4K | -55.2% ▼ | |
| Sennosides | 15 | 4,660 | £92 | -51.4% ▼ |
| Inclisiran | 15 | 15 | £684 | +19.1% ▲ |
| Meptazinol hydrochloride | 15 | 840 | £149 | -54.6% ▼ |
| Valaciclovir | 15 | 250 | £343 | +6.7% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 15 | 99.8K | £1.8K | -78.6% ▼ |
| Ketorolac trometamol | 15 | 75 | £74 | +61.7% ▲ |
| Menthol | 15 | 2,700 | £106 | -46.7% ▼ |
| Azelaic acid | 15 | 480 | £83 | -37.3% ▼ |
| 15 | 7,800 | £79 | -83.5% ▼ | |
| 15 | 580 | £2.8K | +7.2% ▲ | |
| Icosapent | 14 | 1,680 | £1.8K | -26.2% ▼ |
| Clomethiazole | 14 | 1,680 | £820 | +12.4% ▲ |
| Repaglinide | 14 | 1,349 | £121 | -42.1% ▼ |
| Megestrol acetate | 14 | 144 | £83 | +103.9% ▲ |
| Other health supplement preparations | 14 | 420 | £50 | -70.5% ▼ |
| Powder 4.6 kcal/g peptide based formula (0913091) | 14 | 61.6K | £3.8K | +122.2% ▲ |
| Dantrolene sodium | 14 | 872 | £141 | -22.4% ▼ |
| Prednisolone acetate | 14 | 105 | £35 | -23.2% ▼ |
| Triamcinolone acetonide | 14 | 14 | £98 | +36.6% ▲ |
| Zinc oxide | 14 | 2,170 | £77 | -30.4% ▼ |
| Ivermectin | 14 | 630 | £351 | -34.2% ▼ |
| Other toiletry preparations | 14 | 4,200 | £56 | -67.2% ▼ |
| 14 | 1,570 | £296 | -53.1% ▼ | |
| 14 | 1,120 | £884 | +27.9% ▲ | |
| 14 | 420 | £1.2K | +275.2% ▲ | |
| 14 | 5,600 | £52 | -44.3% ▼ | |
| 14 | 609 | £134 | -30.8% ▼ | |
| 14 | 540 | £26 | -74.2% ▼ | |
| 14 | 720 | £2.5K | -37.5% ▼ | |
| 14 | 5,600 | £175 | -9.1% ▼ | |
| 14 | 510 | £239 | +31.6% ▲ | |
| 14 | 660 | £1.6K | -31.7% ▼ | |
| 14 | 340 | £1.1K | +59.8% ▲ | |
| 14 | 330 | £2.2K | +54.0% ▲ | |
| Terazosin hydrochloride | 13 | 728 | £58 | -20.1% ▼ |
| Olmesartan medoxomil/amlodipine | 13 | 364 | £196 | -1.4% vs avg |
| Telmisartan with diuretic | 13 | 364 | £99 | +15.0% ▲ |
| Acrivastine | 13 | 780 | £256 | +5.5% ▲ |
| Alimemazine tartrate | 13 | 3,900 | £9.0K | +0.5% vs avg |
| Haloperidol | 13 | 728 | £199 | -72.7% ▼ |
| Dosulepin hydrochloride | 13 | 364 | £76 | -77.0% ▼ |
| Vancomycin hydrochloride | 13 | 364 | £1.7K | +380.1% ▲ |
| Rifaximin | 13 | 686 | £3.2K | -51.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.